Links
Organizations
Conferences
Info & Opinion
August 22, 2008
Thursday News
Financial Results From etrials
A few news bulletins on Omnicare, CogState, Octagon Research Solutions, Encorium Group, Ricerca Biosciences and etrials.
Wednesday News
PSI Acquires Thywill
A few news bulletins on Asian Clinical Trials, Suven Life Sciences, LAB Research, Omnicare Clinical Research, Bioanalytical Systems, Acurian, Lux Biosciences, PSI and Thywill
Tuesday News
Lilly, i3 Data Deal
News about Clinipace, ICON, Octagon, drug safety in Canada, DIA leadership, AHIC, Lilly and i3 Statprobe.
Monday News
Covance, Lilly Lab Deal
A few news bulletins on DataTrak, Clinilabs, Covance, Eli Lilly, Phase Forward, Velos, United BioSource Corporation, CogState, Parexel International and Chiltern
Thursday News
eRT Earnings Rise 61%
A few news bulletins on Phase Forward, INC Research, eResearchTechnology, Abingdon Life Sciences, Stason Pharmaceuticals, etrials, and OmniComm.
INC Research named David Subich as senior director, clinical operations for metabolic and endocrine diseases. He was formerly a professor at Ohio State. “Subich has a unique combination of research experience and hands-on medical practice in a variety of environments. He has witnessed the rise of metabolic diseases as a… more...
Animal rights activists are personally targeting FDA chief Andrew von Eschenbach, buying a full-page ad to criticize him in the Washington Post. The activists contend 65,000 animals die annually because of pharmaceutical research and say the experiments on beagles and other mammals are antiquated. Here’s the release. Parexel’s acquisition of… more...
Health Market Science, a source of health care provider data and analytics solutions in the U.S., announced the launch of a database called Clinical Investigators, to assist with clinical site recruitment. The company has combined an intuitive web-based user interface with a national, comprehensive database of trial experience detail, claims… more...
Parexel International promoted Mark Goldberg to chief operating officer. He previously served as president of clinical research services and the firm’s technology division, Perceptive Informatics. “His appointment as COO is in recognition of his strong leadership skills and increasing responsibilities, especially as we have expanded our clinical development capabilities and… more...
Althea Technologies, a service provider for pharmaceutical companies, announced that E.J. Brandreth has joined the company as VP of quality and regulatory affairs. “We are very excited to welcome E.J. Brandreth to Althea. The diverse experience he brings to the company is particularly valuable. His background in clinical and commercial… more...
Sundia MediTech was named one of the 50 best companies for investment in China in 2008 by local investors. There were more than 900 entries. “We thank the venture investor community for voting Sundia into Venture 50 again,” said Sundia CEO Xiaochuan Wang, “This award marks another step of Sundia’s… more...
The “approvable” letters that the FDA formerly sent out to gently reject drugs will be dropped in favor of “response” letters. Here’s a Q&A and the official news release. Octagon Research, a provider of systems for regulatory data, said 100 customers are using its Starting Point templates for regulatory documents.… more...
ICD Global, specializing in patient recruiment materials, has developed TrialVision. It’s a proprietary online system to help the industry electronically manage all aspects of their patient recruitment materials supply, from file proofing to production and site delivery. ICD Global designed TrialVision to simplify recruitment materials management, helping customers reduce errors… more...
Iris Pharma, a French contract research organization (CRO) has an alliance with the Institut de la Vision, a research center dedicated to eye diseases. “Iris Pharma found it natural to become involved in a project of such scope and so promising in terms of research and advances in eye diseases.… more...
Leo Pharma, a pharmaceutical company specializing in treatments for dermatological and vascular-related conditions, has upgraded to Oracle Remote Data Capture (RDC) Onsite 4.5.3. The company first deployed Oracle RDC in 2005, which helped it lower time from the last patient visit to database lock from 6-12 weeks to 1-2 weeks.… more...
